JP2005097308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005097308A5 JP2005097308A5 JP2004289801A JP2004289801A JP2005097308A5 JP 2005097308 A5 JP2005097308 A5 JP 2005097308A5 JP 2004289801 A JP2004289801 A JP 2004289801A JP 2004289801 A JP2004289801 A JP 2004289801A JP 2005097308 A5 JP2005097308 A5 JP 2005097308A5
- Authority
- JP
- Japan
- Prior art keywords
- ultrafine
- agent
- glucan
- particles
- average particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011882 ultra-fine particle Substances 0.000 claims 36
- 239000002245 particle Substances 0.000 claims 23
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 14
- 229920002498 Beta-glucan Polymers 0.000 claims 13
- 238000000034 method Methods 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 6
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000002270 dispersing agent Substances 0.000 claims 6
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 235000000346 sugar Nutrition 0.000 claims 4
- 206010010774 Constipation Diseases 0.000 claims 3
- 206010012735 Diarrhoea Diseases 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 230000003308 immunostimulating effect Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 239000000043 antiallergic agent Substances 0.000 claims 2
- 239000003472 antidiabetic agent Substances 0.000 claims 2
- 229940125708 antidiabetic agent Drugs 0.000 claims 2
- 229960005475 antiinfective agent Drugs 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 239000004067 bulking agent Substances 0.000 claims 2
- 208000010643 digestive system disease Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000037406 food intake Effects 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 230000002584 immunomodulator Effects 0.000 claims 2
- 229940121354 immunomodulator Drugs 0.000 claims 2
- 229960001438 immunostimulant agent Drugs 0.000 claims 2
- 239000003022 immunostimulating agent Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 230000036737 immune function Effects 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004289801A JP4752233B2 (ja) | 2001-04-27 | 2004-10-01 | 免疫賦活剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001132513 | 2001-04-27 | ||
| JP2001132513 | 2001-04-27 | ||
| JP2004289801A JP4752233B2 (ja) | 2001-04-27 | 2004-10-01 | 免疫賦活剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002584947A Division JP3633601B2 (ja) | 2001-04-27 | 2002-04-26 | 免疫賦活剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005097308A JP2005097308A (ja) | 2005-04-14 |
| JP2005097308A5 true JP2005097308A5 (enExample) | 2005-09-02 |
| JP4752233B2 JP4752233B2 (ja) | 2011-08-17 |
Family
ID=34466575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004289801A Expired - Lifetime JP4752233B2 (ja) | 2001-04-27 | 2004-10-01 | 免疫賦活剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4752233B2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090009513A (ko) * | 2007-07-20 | 2009-01-23 | 한국원자력연구원 | 방사선 조사에 의한 저 분자량의 베타글루칸의 제조 방법및 방사선 조사에 의하여 제조된 저 분자량의 베타글루칸 |
| JP5928774B2 (ja) * | 2011-11-01 | 2016-06-01 | 株式会社大阪ソーダ | β−１，３−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤 |
| CN102408495B (zh) * | 2011-12-29 | 2013-09-18 | 武汉大学 | 具有抗炎症活性的香菇β-葡聚糖及其制备方法和应用 |
| WO2015083982A1 (ko) * | 2013-12-06 | 2015-06-11 | 한명순 | 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지 |
| MX375742B (es) | 2014-02-03 | 2025-03-06 | Apurano Pharmaceuticals Gmbh | Nanosuspension de materiales naturales y metodo de preparacion del mismo. |
| KR102836700B1 (ko) * | 2022-06-27 | 2025-07-21 | (주)에이치케이바이오텍 | 표고버섯 균사체 복합 배양물(hksmm)을 유효성분으로 함유하는 항염증 또는 면역증진용 조성물 및 표고버섯 균사체 복합 배양물(hksmm)의 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02174722A (ja) * | 1988-09-01 | 1990-07-06 | Kureha Chem Ind Co Ltd | かわらたけ由来の蛋白多糖体の粒状製剤 |
| US6284886B1 (en) * | 1998-05-27 | 2001-09-04 | Ceapro Inc | Cereal beta glucan compositions and methods of Formulation |
| DE19911058B4 (de) * | 1999-03-12 | 2004-09-30 | Biotec Asa | Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen |
| JP3622595B2 (ja) * | 1999-10-15 | 2005-02-23 | 王子製紙株式会社 | 担子菌を含有する健康食品、飼料ならびにペットフード |
-
2004
- 2004-10-01 JP JP2004289801A patent/JP4752233B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104755092A (zh) | 用于递送协同免疫作用的包含微粒和益生菌的组合物 | |
| JP6441821B2 (ja) | 感染症の治療に用いる合成または組換えフコシル化オリゴ糖 | |
| WO2007035057A1 (en) | Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients | |
| JP7024975B2 (ja) | 糖及び／又は脂質の代謝改善剤 | |
| CN1288730A (zh) | 轻泻组合物 | |
| CN103025340B (zh) | 芦荟(Aloe vera)组合物及其在制备抗病毒和治疗获得性免疫缺陷综合征(AIDS)药物中的应用 | |
| CN101474375B (zh) | 复方蛹虫草制剂及制法与应用 | |
| JP6242696B2 (ja) | 腸管免疫賦活剤 | |
| TW200900053A (en) | Medical uses of glucans | |
| JP2005097308A5 (enExample) | ||
| CN113892650A (zh) | 一种益生菌脂质体及其制备方法 | |
| JP5395733B2 (ja) | ビフィズス菌属の細菌の成長を促進し、顆粒球コロニー刺激因子の放出を促進し、ｔヘルパー細胞タイプｉの分化を促進し、及び／又はｔヘルパー細胞タイプｉｉの分化を抑制するためのキバナシュスラン種・多糖類抽出物及び医薬組成物、及びその調製方法 | |
| CN103622951B (zh) | 莲必治口服液体制剂其制备方法 | |
| WO2007140681A1 (fr) | Utilisation de cucurbitacines ou de compositions à base de cucurbitacine pour la préparation de médicaments destinés à augmenter le nombre de leucocytes | |
| EP2635130B1 (en) | Composition of purified soluble mannans for dietary supplements and methods of use thereof | |
| US20090169557A1 (en) | Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies | |
| JP4450571B2 (ja) | リポソーム含有経口摂取用組成物 | |
| EP2486931B1 (en) | Therapeutic agent for influenza virus infectious diseases | |
| Cerletti et al. | Edible mushrooms and beta-glucans: Impact on human health. Nutrients 2021; 13: 2195 | |
| CN1771936A (zh) | 一种稳定的青蒿素及青蒿素衍生物药物组合物 | |
| CN1411739A (zh) | 魔芋葡甘聚糖降解物与银杏叶提取物保健食品及制备方法 | |
| JP2004224772A (ja) | サッカロミセス酵母のマンナンを有効成分とするアレルギー体質改善剤 | |
| CN103463453A (zh) | 一种金钗石斛片剂及其提取、制备方法 | |
| JP7645056B2 (ja) | 生活習慣病予防または改善用組成物 | |
| JP2004107281A (ja) | 酵母細胞壁を有効成分とする消化管免疫賦活剤および飲食品 |